JohnM.RoutesMD

Summary

• Dr. Routes graduated from Indiana University School of Medicine, and received his Internal Medicine training at the University of Utah, Fellowship training in Allergy and Clinical Immunology at National Jewish Health and the University of Colorado School of Medicine, where he was a faculty member for over twenty years. In 2006, he became head of the Allergy and Clinical Immunology Division in the Department of Pediatrics at Medical College of Wisconsin (MCW) and established the Primary Immunodeficiency Program at MCW. In 2008, Dr. Routes was the principal investigator for the first statewide program (Wisconsin) to screen all newborns for severe combined immunodeficiency (SCID). In 2010, Dr. Routes testified at the HHS subcommittee, the Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children, on Wisconsin’s successful, statewide implementation of newborn screening of infants with SCID, which resulted in the addition of SCID to the recommended panel of newborn screening tests by the United States government. He also has a longstanding interest in lung disease in primary immunodeficiencies and was the corresponding author describing granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiencies as a unique disease, which is distinct from sarcoidosis. He subsequently has published on the successful use of immunosuppressive therapy to treat this disorder. He has been a reviewer on several NIH study sections and served as Chair of the NIH Study Section “Investigations on Primary Immunodeficiencies”. Dr. Routes was elected as President of the Clinical Immunology Society (CIS) in 2012-2013 and in 2016 received the CIS Distinguished Service Award.